- Home
- MBIO vs JZ Comparison
MBIO vs JZ Comparison
Compare MBIO & JZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MBIO
- JZ
- Stock Information
- Founded
- MBIO 2015
- JZ 2011
- Country
- MBIO United States
- JZ China
- Employees
- MBIO N/A
- JZ N/A
- Industry
- MBIO Biotechnology: Pharmaceutical Preparations
- JZ Other Consumer Services
- Sector
- MBIO Health Care
- JZ Real Estate
- Exchange
- MBIO Nasdaq
- JZ Nasdaq
- Market Cap
- MBIO 4.7M
- JZ 4.9M
- IPO Year
- MBIO N/A
- JZ 2022
- Fundamental
- Price
- MBIO $1.50
- JZ $1.67
- Analyst Decision
- MBIO
- JZ
- Analyst Count
- MBIO 0
- JZ 0
- Target Price
- MBIO N/A
- JZ N/A
- AVG Volume (30 Days)
- MBIO 127.7K
- JZ 7.3K
- Earning Date
- MBIO 11-12-2025
- JZ 10-16-2025
- Dividend Yield
- MBIO N/A
- JZ N/A
- EPS Growth
- MBIO N/A
- JZ N/A
- EPS
- MBIO N/A
- JZ N/A
- Revenue
- MBIO N/A
- JZ $34,090,704.00
- Revenue This Year
- MBIO N/A
- JZ N/A
- Revenue Next Year
- MBIO N/A
- JZ N/A
- P/E Ratio
- MBIO N/A
- JZ N/A
- Revenue Growth
- MBIO N/A
- JZ N/A
- 52 Week Low
- MBIO $0.89
- JZ $1.30
- 52 Week High
- MBIO $21.95
- JZ $14.60
- Technical
- Relative Strength Index (RSI)
- MBIO 44.43
- JZ 49.27
- Support Level
- MBIO $1.43
- JZ $1.64
- Resistance Level
- MBIO $1.69
- JZ $1.88
- Average True Range (ATR)
- MBIO 0.11
- JZ 0.10
- MACD
- MBIO -0.01
- JZ 0.01
- Stochastic Oscillator
- MBIO 17.07
- JZ 43.23
About MBIO Mustang Bio Inc.
Mustang Bio Inc is a clinical-stage biopharmaceutical company focused on translating today's medical breakthroughs in cell and gene therapy into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline is currently focused on the core areas of gene therapies for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (CAR T) therapies for hematologic malignancies, and CAR T therapies for solid tumors.
About JZ Jianzhi Education Technology Group Company Limited
Jianzhi Education Technology Group Co Ltd engages in developing educational content to fulfill the massive demand for high-quality, professional development training resources in China. The company and its subsidiaries VIE and VIEs generate subscription revenue through selling subscriptions to online learning platforms, higher education institutions, and other institutional customers under a B2B2C model mainly through the platform of Sentu Academy; offering subscriptions concerning educational content in mobile video packages directly to end users under a B2C model through the platforms such as Fish Learning or Light Class, etc. It has two operating segments: Educational content services and other services and IT-related solution services.